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Abstract. In a health system increasingly driven by cost constraints, there is a focus
on improved electronic transfer of information to support healthcare delivery. One
area of healthcare that has moved more quickly than others to achieve this is
prescribing in the primary care environment. Whilst the move to electronic transfer
of prescriptions has reduced transcription errors, the regulatory environment
persists with handwritten signatures. This constraint, whilst addressed slowly with
technology solutions, needs support from legislative change. The ultimate step is to
have a secure mobile model, which would support the move to a fully-electronic,
paperless transaction model.
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Introduction
The National Health and Hospital Reform Commission (NHHRC) recognises that ehealth plays a vital role in realising Australia’s health reform recommendations [1], and
is the key to improving Australian healthcare system whilst supporting a maintainable
system [2]. Electronic Transfer of Prescriptions (eTP) is an important contributor in an
e-health-enabled healthcare system that ensures medicines information is accurately and
securely shared, providing a range of healthcare benefits for both prescribers and
consumers [3, 4]. In an environment where 209.8 million prescriptions were filled in the
2013-2014 financial year, an increase of 6.3% on 2012-2013, streamlining the
prescription process is vital [5]. This is achieved through sharing of precise patient
medication information between prescriber and dispenser [3]. The eTP process allows
for electronic generation of a prescription by a prescriber and electronic signature
authentication, which is then transmitted securely to a pharmacy.
As the demand for mobile applications to support healthcare provision grows, there
is a need to explore opportunities and seek solutions to the issues of secure transmission
and use of data for health in a mobile environment. This paper uses eTP as an example
of the pathway of technological development from the paper based manual prescription
process to a fully mobile, paperless paradigm. It reviews the existing methods of
transfer of prescription information including current practice, software capabilities, and
regulation and legislative constraints at the Commonwealth, State, and Territory levels.
Instead of simply providing a comparative review of various implementations, it
presents a snapshot of the current situation in order to provide a context and further it
proposes a new mobile fully-electronic solution.
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1. Methods for Transfer of Prescriptions
As both hardware and software technology have evolved, there has been a progression
in information transfer from a manual prescribing process to a hybrid manual/electronic
solution. Figure 1 demonstrates the conventional manual prescribing model with the
prescriber writing on a pre-printed prescription pad. Once signed, the prescription is
given to the patient, who then presents it to the pharmacy where the prescription details
are transcribed into an electronic pharmacy dispensing system for dispensing. This
information is also used for Pharmaceutical Benefits Scheme (PBS) claiming and repeat
dispensing. This process may include verification of the prescription details with the
prescriber, and it is vulnerable to loss of the prescription by the patient, as well as
transcription errors in the pharmacy data-entry process.

Figure 1. Manual prescribing process.

The introduction of the Practice Incentive Program (PIP) by the Australian
Government for desktop computing in general practice in the late 1990’s, saw the
transition to printed prescriptions and subsequently electronic process inclusion as part
of the prescribing workflow [6].

Figure 2. Current electronic prescription transfer process.

Figure 2 describes the prescribing model currently used by 95.7% of GPs in
Australia [7]. This model implements eTP technical specification. eTP version 1.1 uses
the Prescription Exchange Service (PES), Electronic Prescribing System (EPS) and
Electronic Dispensing System (EDS) as key elements:
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x

The Prescription Exchange Service (PES) is an intermediary service, which
enables secure transmission of electronic prescription information between
prescribers and dispensers [8].
x The Electronic Prescribing System (EPS) is a component of the prescriber’s
clinical software package for generating an electronic prescription, digitally
signing it and uploading it to the PES [8].
x The Electronic Dispensing System (EDS) is a pharmacy software component,
which downloads the electronic prescription from the PES and submits
dispense-records to the PES upon dispensing [8].
In this model, GPs use clinical software that has an EPS component for generating
prescriptions and upload to one of two script exchanges (PES). Each electronically
generated prescription is identified by a unique Document Access Key (DAK), which is
provided to the patient encoded as a barcode on the printed and signed Prescription
Notification slip. The slip contains information identical to the prescription. When the
slip is presented to the pharmacy, the prescription detail is downloaded by the
pharmacy’s eTP enabled EDS from the PES, using the DAK, as shown in Figure 2. This
eliminates the need for verification of the prescription details, and transcription errors.
The downloaded prescription is used to dispense the medication and for secondary uses
such as PBS claiming. The EDS then provides a record of the dispensed medication to
the PES. Whilst existing, the automatic dispense notification service to the originating
prescriber is currently disabled at the request of the Royal Australian College of General
Practitioners, due to potential implications for clinician duty of care [12].
A mobile application from one PES supplier was released in 2014 to enhance this
process model (Figure 2) by allowing patients to scan the DAK barcode from the
prescription to their mobile phone, and submit it to their choice of pharmacy, securely
for a scheduled pickup. This model still uses the printed Prescription Notification with
prescription details as a transfer medium for passing the DAK between the prescriber
and dispenser. The prescriber’s signature on the printed prescription is mandated by
relevant Acts/Regulations (e.g. Poison Regulation 1965 Regulation 51.(1B) in Western
Australia). This requirement will be replaced once the use of digitally signed electronic
prescriptions has legislative approval.

2. Adoption Potential and Related Issues
Figure 3 depicts the levels of eTP adoption, the extent to which eTP is implemented,
and its influence on the information workflow and the form in which the information is
communicated. The level of adoption of eTP varies across the different sectors of the
healthcare industry, despite being a key government initiative to improve the delivery
and quality of healthcare.
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Figure 3. Level of eTP adoption [9].

In Level 1 the printed prescription is both the legal prescription for dispensing and
the transfer medium for delivering the DAK identifier to the dispenser. Having the
prescription details printed with the DAK benefits the patient, as the printed prescription
details may be used for dispensing if the pharmacy’s EDS is not eTP enabled or access
to PES is not available. However, this requires the printed prescription to have the
prescriber’s handwritten signature on it as mandated by the s. 51(1B) of the Poisons
Regulations 1965 in WA and similar legislation in other States. However, using a data
storage device as the transfer media for the electronic prescription, instead of the printed
paper version, means the written signature of the prescriber is no longer required as it is
exempted by the s. 51 (1A) and s. 51(1C) of the Poisons Regulations 1965, and s. 9(1)
and s. 9(3) of the Electronic Transaction Acts 1999.
Level 2 adoption uses the printed prescription notification as a transfer medium for
delivering the identifying DAK to the dispenser. The printed prescription notification
also contains the same prescription details as the electronic prescription thus facilitating
dispensing if access to PES is not available. However, the same principles and
restrictions apply as in Level 1 with regard to the prescriber’s handwritten signature. In
the current electronic prescription transfer process, the pharmacy’s eTP enabled EDS
downloads the prescription details from the PES using the DAK, upon receiving the
printed prescription or the prescription notification submitted by the patient/agent.
Level 3 allows for the same conditions as Level 2 but replaces the paper
notification with a fully-electronic notification.

3. Designing Solutions to Meet Compliance
Whilst the Australian Government has removed Commonwealth legislative barriers to
electronic prescribing, by implementing changes to the National Health (Pharmaceutical
Benefits) Amendment Regulations 2006, the State and Territory legislative barriers
remain. Alignment with Commonwealth amendments is occurring slowly, and this will
provide rules for electronic prescribing and dispensing in the respective jurisdictions.
Table 1 lists the Commonwealth, as well as State and Territory Acts and Regulations
that have been repealed and/or amended to accommodate implementation of eTP.
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Table 1. Commonwealth, State and Territory Acts enabling the implementation of eTP.
Jurisdiction

Acts/Regulation

Commonwealth Electronic Transactions Act 1999
Commonwealth National Health Act 1953; National Health (Pharmaceutical Benefits) Regulations 1960
NSW

Poisons and Therapeutic Goods Regulation 2008

VIC

Drugs, Poisons and Controlled Substances Regulations 2006

QLD

Health (Drugs and Poisons) Regulation 1996

WA

Poisons Act 1964; Poisons Regulations 1965

SA

Controlled substances Act 1984; Controlled substances (Poisons) Regulations 2011

TAS

Poisons Act 1971; Poisons Regulations 2008

ACT

Medicines, Poisons and Therapeutic Goods Act 2008; Medicines, Poisons and
Therapeutic Goods Regulations 2008

NT

Medicines, Poisons and Therapeutic Goods Act 2012

Other standards, specifications, and principles that support and govern the
implementation of eTP in Australia include: Electronic Transactions Act 1999
(Commonwealth) and Electronic Transactions Act 2011 (WA), Australian Privacy
Principles 2014, ATS 4888.1–7 (2013) Electronic transfer of prescriptions using Health
Level 7 (HL7) Clinical Document Architecture (CDA), and AS 4700.3-2014 Electronic messages for exchange of information on medicines prescription using HL7
V2.5. Whilst not exhaustive, this highlight the complexity of designing solutions. In
other words, these Acts, regulations, and standards influence the legislative
requirements and specifications that must be met in design and development of eTP.

4. A New, Fully Mobile Solution
Whilst the Electronic Transactions Act 1999 primarily supports the creation, transfer
and storage of the electronic prescription, amendments 51(1A) and 51(1C) of the
Poisons Regulations 1965 effectively allows an electronic prescription to be a legal
document without the prescriber’s written signature. Combined with other changes in
governance the Commonwealth and States have made to enable e-health, these two
amendments are sufficient to support an ETP Level 3 model.

Figure 4. Proposed fully-electronic mobile prescription transfer process.

A fully-electronic mobile prescription transfer model is proposed (Figure 4). The
EPS generates an electronic prescription, encrypts it using the DAK as per the data
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security conformance guidelines in ATS4888.2, signs the DAK with the prescriber’s
Medicare digital certificate, and then transfers it to the patient’s mobile device. The use
of digital certificates not only provides a way to authenticate the prescriber but also
assures the confidentiality and integrity of the information transferred. The encrypted
electronic prescription is stored on the mobile device in the same way it is stored within
the PES in the current prescribing model. When presented at the pharmacy, the
encrypted prescription and DAK are transferred to the pharmacy system, the
prescriber’s digital certificate is verified, and then the prescription is decrypted using
the DAK. This model bypasses the PES entirely by using the mobile device as the
transfer medium for the electronic prescription. Once dispensed, the pharmacy’s EDS
uploads the dispensing information into the NPDR. In this model, the prescription is
issued and transferred in fully-electronic form, thus removing the requirement for the
prescriber’s written signature in accordance with section 51(1A) of the Poisons
Regulations 1965.
This proposed eTP transfer model supports eTP adoption stages Levels 1 to 3 as
long as there is a mechanism to transfer the electronic prescription from the prescriber’s
EPS to the mobile storage device and from the mobile storage device to the dispenser’s
EDS securely. This model is envisaged to use Near Field Communication (NFC)
technology as the preferred transfer mechanism. NFC is designed for use in close
proximity (i.e. up to a few centimetres) for secure data transfer and supports strong
security features that facilitate highly secure transfer and storage of data. The NFC
technology’s reliability and practicality is evident by its use in the banking industry (e.g.
Commonwealth Bank for its product, Tap & Pay). Nevertheless, this preference of
employing NFC for data transfer is not based solely on the technical viability but also
on the consumer acceptance and confidence in the technology. NFC’s simplicity from a
user perspective, enables easy information sharing NFC is now available on all recent
model mobile phones. In the current hybrid transfer model, the PES makes uploaded
prescriptions available to dispensers as well as preventing access to those that have been
cancelled, are expired or fully dispensed. For that purpose, PES updates the dispensing
state of each prescription after each dispense. In the proposed model, the smart phone
utilised as the mobile storage device makes the prescription available to the dispensers
and the dispensing state of the prescription is updated by the dispenser’s EDS directly to
the mobile storage device. Due to the connectionless nature of the proposed model,
cancelling the prescription by the prescriber requires additional services such as SMS to
update remotely the dispensing state of the prescriptions stored on the mobile device

5. Conclusion
The Commonwealth, States, and Territories have repealed and/or amended Acts and
Regulations, and developed and adopted many standards and specifications in order to
pave the way for implementing eTP. The legislative approval for the legal use of
digitally signed electronic prescription is one of the last steps supporting the efficient
use of electronic information communication in electronic prescribing. The proposed
model can be implemented within the existing legislative framework, reduces
complexity, and removes the need for ongoing major supporting infrastructure with its
associated cost. In addition, users will be empowered and reassured that their sensitive
medication data is not available to third parties. The model is very efficient and does not
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require internet connectivity for basic functionality. Therefore, it provides an effective
solution in all areas including remote locations with poor or no connectivity.
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